Humana Inc Raises FY 2012 EPS Guidance; Issues FY 2013 EPS Guidance Below Analysts' Estimates

Humana Inc announced that it anticipates EPS of approximately $7.25 to $7.35 for fiscal 2012 versus its previous estimate of $6.90 to $7.10, driven primarily by favorable prior-year medical claims reserve development and improved stand-alone Prescription Drug Plan (PDP) results. Looking ahead to fiscal 2013, the Company projects EPS to be in the range of $7.60 to $7.80, a growth rate of 5% at the mid-point versus the mid-point of the Company's fiscal 2012 EPS guidance. Results for fiscal 2013 are expected to include approximately $0.30 per share as the company accelerates investments in integrated care delivery models in key markets to ready itself for the future health care environment. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $7.14 for fiscal 2012 and EPS of $7.87 for fiscal 2013.